DrugCard

DrugCard: AI-Powered Pharmacovigilance for Local Literature Screening

What is DrugCard?

DrugCard is an AI-driven data intelligence platform designed to streamline and enhance pharmacovigilance processes. It specializes in automating the screening of local medical literature to ensure comprehensive drug safety monitoring. By leveraging AI, DrugCard offers a continuous, regular, transparent, multi-language, and cost-effective solution for pharmaceutical companies, CROs, and freelancers.

How does DrugCard work?

DrugCard monitors medical journals across 104+ countries in over 100 languages. It uses AI to analyze and extract relevant data, providing users with accurate, complete, and holistic information. The platform supports multi-region suppliers and requires no CAPEX investments, making it a scalable and cost-effective solution.

Key Features and Benefits:

• Continuous and Regular Monitoring: Ensures constant surveillance of local medical literature.
• Traceable and Transparent: Provides clear and auditable processes.
• Accurate, Complete, Holistic Data: Delivers comprehensive insights for informed decision-making.
• Scalable to New Markets: Easily adapts to expanding business needs.
• Multi-Language Support: Screens literature in over 100 languages.
• Cost-Effective: Reduces time and resources spent on manual screening.

Why Choose DrugCard?

In today's rapidly evolving pharmacovigilance landscape, pharmaceutical companies face numerous challenges, including:

• AI Competition: New entrants with AI technology are disrupting the status quo.
• Tech/Digital Age: Investments in new technologies require longer payback periods with shorter change cycles.
• Audits/Regulatory Pressure: Increasing audits and non-compliance cases demand more stringent processes.
• Rising People Costs: High retention costs and investments in staff training strain budgets.
• Global Pressures: New requirements for drug safety processes are emerging.

DrugCard addresses these challenges by:

• Saving Time: Up to 60% time savings compared to manual screening.
• Improving Efficiency: Automating critical processes to focus on high-priority tasks.
• Ensuring Compliance: Meeting global regulatory requirements.
• Reducing Costs: Lowering operational expenses through automation.

Who is DrugCard for?

DrugCard is ideal for:

• CROs (Contract Research Organizations): Manage more pharmacovigilance projects and improve screening results.
• MAHs (Marketing Authorization Holders): Ensure full compliance with regulatory requirements.
• Freelancers: Enhance productivity and deliver high-quality results.

Testimonials

• Dovilė Marcinkė, Head of Global Drug Safety Unit and QPPV: "Drugcard has allowed us to automate a critical process in our work: local literature monitoring. Not only does it save time, but it also captures more information than we could gather manually."
• Jaime Ruiz, Senior Pharmacovigilance Specialist: "DrugCards stands out as a mandatory operation tool, enabling our presence and activities with efficiency, cost saving and compliance with GVP regulations and other applicable requirements."
• Cristina Ruiz, PV Project Manager: "No more spending hours reading articles, since we started working with Drugcard we are more productive in other tasks. It is a very reliable tool that has certainly helped us a lot in the team. 100% recommendable!"

How to use DrugCard?

1. Schedule a Meeting: Contact DrugCard to discuss your specific needs.
2. Request a Demo: Experience the platform's capabilities firsthand.

FAQ

• How much time can I save when using DrugCard? Up to 60% compared to manual screening.
• Can DrugCard recognize poorly scanned texts? Yes.
• Can DrugCard screen local medical journals in local languages? Yes, in over 100 languages.
• Can I have weekly reports with all data collected in a week? Yes.

Conclusion

DrugCard is a powerful AI-driven tool that revolutionizes pharmacovigilance by automating local literature screening. Its continuous monitoring, multi-language support, and cost-effectiveness make it an essential solution for pharmaceutical companies, CROs, and freelancers seeking to enhance drug safety and compliance. By adopting DrugCard, organizations can save time, reduce costs, and ensure comprehensive monitoring of local medical literature, ultimately driving pharmacovigilance forward with AI-enabled data intelligence.